<DOC>
	<DOCNO>NCT02911623</DOCNO>
	<brief_summary>To observe early safety performance Shockwave Medical Lithoplasty® System ( specifically , Lithoplasty® Catheters : 2.5 x 60mm , 2.75 x 60mm , 3.0 x 60mm , 3.25 x 60mm , 3.5 x 60mm ) subject demonstrate Shockwave device safely effectively deliver localize pulsatile mechanical energy balloon dilation calcify , stenotic , infrapopliteal artery .</brief_summary>
	<brief_title>Safety Feasibility Shockwave Lithoplasty® System Treatment Peripheral Vascular Stenosis</brief_title>
	<detailed_description>Shockwave Medical , Inc. intend conduct prospective , single-arm , multi-center , clinical study design evaluate early safety performance Shockwave Lithoplasty® System subject moderate heavily calcified peripheral artery 2.5mm 3.5mm reference vessel diameter target site . The Shockwave Lithoplasty® System indicate lithotripsy-enhanced , low-pressure balloon dilation calcify , stenotic peripheral artery patient candidate percutaneous therapy . Up twenty subject enrol treat Lithoplasty® System .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>1 . Subject able willing comply assessment study . 2 . Subject subject 's legal representative inform nature study , agree participate sign approve consent form . 3 . Age subject &gt; 18 . 4 . Rutherford Clinical Category 1 5 . Angiographic 1 . Single multiple target lesion ( ) is/are locate de novo artery distal trifurcation vessel extend end ankle 2 . Target vessel reference diameter 2.5mm 3.5mm visual estimate 3 . Target lesion diameter stenosis ≥50 % investigator via visual estimate 4 . If inflow disease &gt; 50 % proximal trifurcation vessel present , treated POBA , stent Lithoplasty without complication . 5 . Target lesion ≤150mm length 6 . Subject least one patent tibial vessel ( &gt; 50 % ) runoff foot . 7 . No evidence aneurysm acute thrombus target vessel . 8 . Any presence calcification within target lesion assess imaging ( radiograph , CT angiography ) . 1 . Rutherford Clinical Category 6 . 2 . Target lesion within low extremity vessel &lt; 50 % stenosis . 3 . Gangrene low extremity . 4 . Planned major amputation target leg . 5 . Previously implanted stent treatment lesion 6 . Target lesion length exceed 150mm . 7 . Patient chronic total occlusion target lesion . 8 . Patient significant stenosis ( &gt; 50 % stenosis ) occlusion inflow tract ( e.g. , iliac common femoral ) successfully treat POBA , stent Lithoplasty without complication . 9 . Patient antiplatelet , anticoagulant , thrombolytic therapy contraindicate . 10 . Patient know allergy contrast agent medication use perform endovascular intervention adequately pretreated . 11 . Patient know allergy urethane , nylon , silicone . 12 . Patient pregnant nursing . 13 . Patient participate another research study involve investigational agent ( pharmaceutical , biologic , medical device ) reach primary endpoint .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>